U.S. District Judge Reed O'Connor has ruled that the Affordable Care Act's mandate for free coverage of HIV prevention drugs violates the religious freedom of a Christian-owned company, Bloomberg reports.
Braidwood Management Inc. had challenged the provision requiring it to cover Truvada and Descovy, a pair of widely-used pre-exposure prophylactic drugs more commonly known as PrEP. Thousands of Americans — especially gay and bisexual men — take PrEP daily as a preventative measure against HIV.
In their initial complaint, the plaintiffs argued that the ACA mandate "forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use." O'Connor ultimately sided with the plaintiffs, claiming the defendants did not show a "compelling interest in forcing private, religious corporations to cover PrEP drugs with no cost-sharing and no religious exemptions."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The suit was led by attorney Jonathan Mitchell, the former Republican solicitor general of Texas who is known for his efforts to restrict abortion access in the state. Mitchell argues that the entire preventive services mandate under the ACA is invalid because those who manage the list are too empowered to not have Senate confirmation, Bloomberg writes.
At this time, it's unclear whether O'Connor's ruling will be nationally endorsed; still, it could have a major impact on access to preventative care and important free health services for Americans. "It's a disappointing decision because it has broader implications for harm for folks that are just trying to work and live and access health care," attorney Shelley Skeen told NBC News.
-
‘Congratulations on your house, but maybe try a greyhound instead’Instant Opinion Opinion, comment and editorials of the day
-
How climate change poses a national security threatThe explainer A global problem causing more global problems
-
The 5 best TV shows about the mobThe Week Recommends From the show that launched TV’s golden age to a Batman spin-off, viewers can’t get enough of these magnificent mobsters
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
Is this the end of ultraprocessed foods?Today's Big Question California law and the MAHA movement are on the same track
-
Bluetoothing: the phenomenon driving HIV spike in FijiUnder the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
‘Nightmare bacteria’ are rapidly spreadingUnder the radar The infections are largely resistant to antibiotics
-
Kissing bug disease has a growing presence in the USThe explainer The disease has yielded a steady stream of cases in the last 10 years
